Latest News and Press Releases
Want to stay updated on the latest news?
-
The CHMP positive opinion is based on the EFFISAYIL® 2 trial, which showed that no flares were observed after week 4 of SPEVIGO® administered subcutaneously. During the 48-week trial, an 84% reduction...
-
Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue1,2,3,4In China,...
-
BIRMINGHAM, Ala., July 29, 2021 (GLOBE NEWSWIRE) -- Gulf Pacific Power (“GPP”), through its subsidiary Georgia Gulf Power Holdings, LLC has completed the acquisition of a 50% stake in AL...
-
BIRMINGHAM, Ala., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Harbert Management Corporation (“HMC”) is pleased to announce that Gulf Pacific Power, LLC (“GPP”) has completed the acquisition of an 80% stake...